Cipla dans l'actualité
Leader pharmaceutique mondial
Tamtam a trouvé 20 articles récents sur Cipla.
- Cipla and 3 other fundamentally strong stocks with low debt and PE less than the industry
- Stocks in news: Jio Financial, Adani Green, Nestle, Cipla, IOC, Waaree Energies
- Cipla shares rise over 1% as pharma major launches obesity, diabetes treatment drug in India
- Cipla Launches Yurpeak in India, a Weekly Tirzepatide Injection for Obesity and Diabetes
- Cipla debuts weight-loss drug Tirzepatide second brand Yurpeak
- Cipla Launches New Drug: ఊబకాయానికి సిప్లా ఔషధం
- From IndiGo, LIC, Cipla to TCS – Here are 10 stocks to watch
- Fox Mandal & Associates acts on Cipla acquiring Inzpera Healthsciences
- Cipla Launches Yurpeak for Obesity, Diabetes in India; Stock Ends 1.5% Higher
- Stocks to Watch Today – Tata Steel, Cipla, SBI and Market Highlights December 11
- Cipla launches Yurpeak (tirzepatide) for obesity and type 2 diabetes management in India
- Cipla Ltd Receives ESG Rating of 66 for FY 2024-25
- Cipla receives ESG rating of 66
- Cipla launches Yurpeak for treatment of obesity and type 2 diabetes
- Cipla launches drug for obesity, diabetes
- Cipla launches Yurpeak for obesity and type 2 diabetes
- Cipla launches Mounjaro twin 'Yurpeak' for small-town India
- Stocks to Watch Today: Tata Steel, Ashoka Buildcon, Purvankara, Prestige Estates, Cipla, SBI Life...
- Venus Remedies Receives Final 110 Mln Rupees Payment From Cipla
- Investing in Cipla (NSE:CIPLA) five years ago would have delivered you a 109% gain
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme Cipla ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires